Cargando…
Therapeutic limitations in tumor-specific CD8+ memory T cell engraftment
BACKGROUND: Adoptive immunotherapy with cytotoxic T lymphocytes (CTL) represents an alternative approach to treating solid tumors. Ideally, this would confer long-term protection against tumor. We previously demonstrated that in vitro-generated tumor-specific CTL from the ovalbumin (OVA)-specific OT...
Autores principales: | Bathe, Oliver F, Dalyot-Herman, Nava, Malek, Thomas R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC183847/ https://www.ncbi.nlm.nih.gov/pubmed/12882650 http://dx.doi.org/10.1186/1471-2407-3-21 |
Ejemplares similares
-
Tumor-specific CD4(+) T cells maintain effector and memory tumor-specific CD8(+) T cells
por: Church, Sarah E, et al.
Publicado: (2014) -
Impact of maternal engrafted cytomegalovirus‐specific CD8(+) T cells in a patient with severe combined immunodeficiency
por: Koh, June‐Young, et al.
Publicado: (2021) -
Inflammatory monocytes promote pre-engraftment syndrome and tocilizumab can therapeutically limit pathology in patients
por: Jin, Linlin, et al.
Publicado: (2021) -
Avidity maturation of memory CD8 T cells is limited by self-antigen expression
por: Turner, Michael J., et al.
Publicado: (2008) -
Distinct Effects of IL-18 on the Engraftment and Function of Human Effector CD8(+) T Cells and Regulatory T Cells
por: Carroll, Richard G., et al.
Publicado: (2008)